| NCT ID | NCT01524276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medtronic |
| Condition | Cardiac Rhythm Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2012-01 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2012-01 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Eligibility Criteria
Inclusion Criteria: * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment Exclusion Criteria: * Patient who is, or will be, inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Contact & Investigator
Medtronic Product Surveillance Registry
✉ rs.productsurveillanceregistry@medtronic.comFrequently Asked Questions
Who can join the NCT01524276 clinical trial?
This trial is open to participants of all sexes, studying Cardiac Rhythm Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01524276 currently recruiting?
Yes, NCT01524276 is actively recruiting participants. Contact the research team at rs.productsurveillanceregistry@medtronic.com for enrollment information.
Where is the NCT01524276 trial being conducted?
This trial is being conducted at Birmingham, United States, Huntsville, United States, Chandler, United States, Phoenix, United States and 11 additional locations.
Who is sponsoring the NCT01524276 clinical trial?
NCT01524276 is sponsored by Medtronic. The trial plans to enroll 100,000 participants.